1. Home
  2. PLUS vs CLDX Comparison

PLUS vs CLDX Comparison

Compare PLUS & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUS
  • CLDX
  • Stock Information
  • Founded
  • PLUS 1990
  • CLDX N/A
  • Country
  • PLUS United States
  • CLDX United States
  • Employees
  • PLUS N/A
  • CLDX N/A
  • Industry
  • PLUS Retail: Computer Software & Peripheral Equipment
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PLUS Technology
  • CLDX Health Care
  • Exchange
  • PLUS Nasdaq
  • CLDX Nasdaq
  • Market Cap
  • PLUS 2.0B
  • CLDX 1.9B
  • IPO Year
  • PLUS 1996
  • CLDX 2008
  • Fundamental
  • Price
  • PLUS $91.15
  • CLDX $26.26
  • Analyst Decision
  • PLUS
  • CLDX Buy
  • Analyst Count
  • PLUS 0
  • CLDX 10
  • Target Price
  • PLUS N/A
  • CLDX $43.80
  • AVG Volume (30 Days)
  • PLUS 182.9K
  • CLDX 919.7K
  • Earning Date
  • PLUS 11-06-2025
  • CLDX 11-10-2025
  • Dividend Yield
  • PLUS 1.10%
  • CLDX N/A
  • EPS Growth
  • PLUS 14.25
  • CLDX N/A
  • EPS
  • PLUS 4.60
  • CLDX N/A
  • Revenue
  • PLUS $2,285,906,000.00
  • CLDX $2,599,000.00
  • Revenue This Year
  • PLUS $7.12
  • CLDX N/A
  • Revenue Next Year
  • PLUS N/A
  • CLDX N/A
  • P/E Ratio
  • PLUS $19.75
  • CLDX N/A
  • Revenue Growth
  • PLUS 9.24
  • CLDX N/A
  • 52 Week Low
  • PLUS $53.83
  • CLDX $14.40
  • 52 Week High
  • PLUS $93.37
  • CLDX $29.05
  • Technical
  • Relative Strength Index (RSI)
  • PLUS 70.63
  • CLDX 55.94
  • Support Level
  • PLUS $87.20
  • CLDX $24.53
  • Resistance Level
  • PLUS $91.91
  • CLDX $26.10
  • Average True Range (ATR)
  • PLUS 3.53
  • CLDX 1.33
  • MACD
  • PLUS 0.49
  • CLDX 0.22
  • Stochastic Oscillator
  • PLUS 89.54
  • CLDX 91.83

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: